Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial
Journal article published in 2021 by
Samer Gawrieh,
Mazen Noureddin,
Nicole Loo,
Rizwana Mohseni,
Vivek Awasty,
Kenneth Cusi,
Kris V. Kowdley 
,
Michelle Lai,
Eugene Schiff,
Deven Parmar,
Pankaj Patel,
Naga Chalasani
,
Michelle Lai,
Eugene Schiff,
Deven Parmar,
Pankaj Patel,
Naga Chalasani
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 